Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
- Author(s)
- Nedumannil, R; Rowland, J; Ashby, M; Hiwase, D; Fleming, S; Malherbe, JAJ; Fairbank, J; Gray, K; Loo, S; Wright, M; Reynolds, J; Marlton, P; Bajel, A; Wei, AH;
- Details
- Publication Year 2025-09-25,Volume 146,Issue #13,Page 1625-1629
- Journal Title
- Blood
- Publication Type
- Research article
- Abstract
- The purpose of this study was to explore and determine the optimal landmark for defining complete remission after intensive induction therapy that best correlates with long-term survival outcome among patients with newly diagnosed acute myeloid leukemia.
- Keywords
- Humans; *Leukemia, Myeloid, Acute/drug therapy/mortality; Remission Induction; Male; Female; Middle Aged; Adult; Aged; *Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Time Factors; Survival Rate; Young Adult; Induction Chemotherapy; Retrospective Studies
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1182/blood.2025028594
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-08-26 11:57:12
Last Modified: 2025-10-02 01:42:12